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Background: Survivors of acute kidney injury are at an increased risk of developing irreversible deterioration in
kidney function and in some cases, the need for chronic dialysis. We aimed to determine predictors of chronic
dialysis and death among survivors of dialysis-requiring acute kidney injury.
Methods: We used linked administrative databases in Ontario, Canada, to identify patients who were discharged
from hospital after an episode of acute kidney injury requiring dialysis and remained free of further dialysis for at
least 90 days after discharge between 1996 and 2009. Follow-up extended until March 31, 2011. The primary
outcome was progression to chronic dialysis. Predictors for this outcome were evaluated using cause-specific Cox
proportional hazards models, and a competing risk approach was used to calculate absolute risk.
Results: We identified 4 383 patients with acute kidney injury requiring temporary in-hospital dialysis who survived
to discharge. After a mean follow-up of 2.4 years, 356 (8%) patients initiated chronic dialysis and 1475 (34%) died.
The cumulative risk of chronic dialysis was 13.5% by the Kaplan-Meier method, and 10.3% using a competing risk
approach. After accounting for the competing risk of death, previous nephrology consultation (subdistribution
hazard ratio (sHR) 2.03; 95% confidence interval (CI) 1.61-2.58), a history of chronic kidney disease (sHR3.86; 95% CI
2.99-4.98), a higher Charlson comorbidity index score (sHR 1.10; 95% CI 1.05-1.15/per unit) and pre-existing hypertension
(sHR 1.82; 95% CI 1.28-2.58) were significantly associated with an increased risk of progression to chronic dialysis.
Conclusions: Among survivors of dialysis-requiring acute kidney injury who initially become dialysis independent, the
subsequent need for chronic dialysis is predicted by pre-existing kidney disease, hypertension and global comorbidity.
This information can identify patients at high risk of progressive kidney disease who may benefit from closer
surveillance after cessation of the acute phase of illness.
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Acute kidney injury (AKI) is a common and serious com-
plication of hospitalization; in severe cases, urgent renal
replacement therapy (hereafter referred to as dialysis) is
needed to address complications of AKI and to support
the patient in overcoming the acute illness. Between 2000* Correspondence: harelz@smh.ca
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unless otherwise stated.and 2009, the incidence of dialysis requiring AKI (AKI-D)
in the United States increased by 10% annually from 222
to 533 cases per million person-years [1]. The increased
incidence of AKI will result in greater numbers of patients
who are faced with persistent health challenges after the
acute phase of their illness has resolved. As a result, acqui-
sition of a better understanding of AKI survivors, who are
at increased risk of progressive kidney disease, and death,
is of vital public health importance [2-5].
Recognition that survivors of AKI are at high risk of
progressive chronic kidney disease (CKD) spurred the
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should be evaluated 3 months after an AKI episode to es-
tablish the presence and extent of chronic kidney disease
[6] However, others have advocated that Nephrology
follow-up occur for all patients with severe AKI [7]. With
almost 1 in 5 adults worldwide experiencing an episode of
AKI during a hospitalization, two percent of whom re-
quire dialysis, such a broad referral strategy may be im-
practical [8]. Identifying AKI-D survivors at the greatest
risk of progressive CKD would potentially lead to the tar-
geted follow-up for individuals who are most likely to
realize a benefit. Accordingly, in a cohort of AKI-D survi-
vors, we performed a study to determine the predictors of
permanent maintenance dialysis and secondarily, death.
Methods
Design and participants
We conducted a retrospective study using population-
wide linked administrative health databases for all of
Ontario, Canada. We identified Ontario residents aged 19
years and older admitted to an acute care hospital between
April 1, 1996 and March 31, 2009, for whom length of stay
was less than 180 days. We focused on individuals who
had a diagnosis of AKI and a claim for acute dialysis during
a hospital stay, and lived for at least 90 days after hospital
discharge without re-initiation of dialysis or rehospitaliza-
tion during this 90-day period. We excluded individuals
with a previous diagnosis of AKI, receipt of a kidney trans-
plant, or any form of dialysis in the 5-year period preced-
ing the index hospitalization. Ontario is Canada’s most
populous province, and all residents are covered by a
government-funded universal healthcare program. No in-
formed written consent was obtained from each individual
included in our study as administrative data was used. The
study was approved by the research ethics board of Sunny-
brook Hospital.
Data sources
The study was completed using linked records from six ad-
ministrative health care databases using encrypted unique
identifiers. Hospitalization records were obtained from the
Canadian Institute for Health Information Discharge Ab-
stract Database (DAD), which was used to identify an acute
hospitalization, the presence of AKI, as well as inpatient co-
morbidities and procedural information on the basis of
codes from the International Classification of Diseases
(ICD 9th or 10th Revision). The Ontario Health Insurance
Plan (OHIP) database provided information on physician
claims for inpatient and outpatient services, including dia-
lysis. (Additional file 1) The Ontario Registered Persons
Database contained basic demographic information for
each eligible individual including date of death. Income
quintile was based on postal codes for residence area as
outlined in the 2001 Statistics Canada Census. Permissionto use these databases was granted by the research ethics
board of Sunnybrook Hospital.
Candidate variable definitions
Candidate variables were selected based on review of the lit-
erature and clinical relevance and encompassed demograph-
ics, comorbidities, features of the index hospitalization, and
markers of health services utilization. (Additional file 1) All
demographic, comorbidity, and health care utilization covar-
iates were ascertained from 5 years preceding the hospital
discharge date except chronic kidney disease which had a
lookback period of 5 years preceding the hospital admission
date. Similar to previous studies, we included both the
Charlson comorbidity index score and the individual com-
ponents of the score in our model, including chronic kidney
disease. The Charlson comorbidity score is a validated
method for estimating the risk of death from comorbid dis-
ease, and has been used in multiple studies [9]. Each comor-
bid condition included in the Charlson index is assigned a
score of 1, 2, 3, or 6, depending on the risk of dying associ-
ated with each condition [9]. The individual scores are
summed to provide a total comorbidity score (Charlson co-
morbidity score) to predict mortality. A standard algorithm
proposed by Quan et al. was used to define the Charlson co-
morbidity score using the DAD [10]. In line with previous
studies, we defined CKD using administrative coding (see
Additional file 2 for codes), which is highly specific but
poorly sensitive (median sensitivity 41%; median specificity
98%) [4,11].
Outcomes
The period of follow-up commenced at day 90 following
discharge for all patients. This period is in line with that
used in other AKI follow-up studies in order to mitigate
bias that may be attributed to the high mortality rate after
discharge among patients with AKI who require tempor-
ary renal replacement therapy likely as a result of the
underlying illness that mediated the AKI [11-13]. The
main outcome was chronic dialysis, which was defined as
the receipt of dialysis for at least 90 days [4]. This defin-
ition is widely accepted and has been used in multiple
studies of AKI [4,5,11]. The date of the first dialysis claim
was considered to be the date of initiation of dialysis. The
secondary outcome was all-cause mortality.Statistical analyses
Baseline characteristics of the study participants were
summarized using descriptive statistics. Continuous vari-
ables were expressed as mean (SD) or median (inter-
quartile range [IQR]) and compared using the unpaired
t-test or Kruskal-Wallis test, respectively. Categorical
variables were expressed as a percentage and compared
using a χ2 test or Fisher’s exact test.
Figure 1 Cohort creation.
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risk analysis
The associations between baseline covariates and out-
comes were assessed using Cox proportional hazards re-
gression. For the primary outcome of chronic dialysis,
subjects were censored in the event of death or at the con-
clusion of follow-up, March 31, 2011. For the all-cause
mortality outcome, subjects were censored at the conclu-
sion of the follow-up, March 31, 2011.
Candidate variables that were associated with the out-
come of interest (P ≤ .10) on univariate analysis and those
that were deemed to be clinically important regardless of
statistical significance were included as potential covari-
ates in the multivariable Cox proportional hazards models.
The presence of collinearity within the models was exam-
ined by evaluation of variance inflation factors. Time-
dependent variables were created to evaluate whether the
proportional hazards assumption was met. In cases where
the proportional hazards assumption was not met, the can-
didate variable was modeled as a time-dependent covariate.
As death was a competing risk for the receipt of chronic
dialysis, using the method of Fine and Gray, we also devel-
oped a semiparametric Cox proportional hazards model
that estimated the risk of chronic dialysis initiation with
death considered as a competing risk [14].
The standard Cox model and the competing risk ap-
proach differ in the way absolute risk predictions are cal-
culated. Whereas predictions from the standard Cox
model depend only on the cause-specific hazard of the
event of interest (receipt of chronic dialysis) and thus
overestimate absolute risk in the presence of a competing
event (death), the competing risk approach consists of de-
veloping a cause-specific hazards models for both the
event of interest (the receipt of chronic dialysis) and the
competing event (death) separately, and then combining
them according to the cumulative incidence function [15].
Model performance
Model discrimination for each of the cause-specific Cox
hazard models (chronic dialysis and all-cause mortality)
was assessed for discrimination using the Harrell global
C-statistic.
Baseline comparisons and development of cause-specific
Cox proportional hazards models were performed using
SAS version 9.1 for UNIX (SAS Institute, Cary, NC), and the
competing risk model was developed using R version 2.9.1
(R Foundation for Statistical Computing, Vienna, Austria).
Results
Characteristics of study participants
We identified 4 383 patients with a previous episode of
AKI-D who survived to 90 days following hospital dis-
charge with no reinitiation of dialysis. (Figure 1) Mean
age was 61 (±16) years, 60% were male and 28% had seena nephrologist prior to the index hospitalization on which
the AKI-D occurred. The median Charlson comorbidity
score was 3 (IQR 1–4). The prevalence of pre-existing cor-
onary artery disease, diabetes, chronic kidney disease, and
cancer were 49%, 44%, 17.2%, and 39% respectively.
Patients who progressed to chronic dialysis (n = 356,
8.1% of cohort ) were older (64 vs. 61 years in patients
with no progression to chronic dialysis, p < 0.01), had a
higher likelihood of previous visit to a nephrologist (60%
vs. 25%, p < 0.01) and cardiologist (61% vs. 46%, p < 0.01),
and had a higher burden of comorbid disease (including car-
diac disease (59% vs. 48%, p < 0.01), congestive heart failure
(54% vs. 36%, p < 0.01), diabetes (61% vs. 43%, p < 0.01),
hypertension (87% vs. 68%, p < 0.01), peripheral vascular dis-
ease (6% vs. 3%, p < 0.01), cancer (43% vs. 39%, p < 0.01),
and chronic kidney disease (57% vs. 14%, p < 0.01)) than
those who did not progress to chronic dialysis (n =
4,027). On the other hand, individuals who progressed
to chronic dialysis were significantly less likely to re-
quire mechanical ventilation (46% vs. 59%, p < 0.01), or
have a diagnosis of sepsis during their index admission
(14% vs. 20%, p < 0.01) (Table 1).
Table 1 Baseline characteristics of the cohort stratified by progression to chronic dialysis
Variable Chronic dialysis No chronic dialysis p-value
N = 356 N = 4,027
Demographics and health utilization
Age, mean (SD) 64 (±14) 61 (±17) <0.01
Female gender, n (%) 143 (40) 1 629 (41) 0.92
Rural locale 53 (15) 548 (14) 0.58
Pre-admission nephrology consultation, n (%) 213 (60) 1 004 (25) <0.01
Pre-admission cardiology consultation, n (%) 216 (61) 1 835 (46) <0.01
Comorbid disease
Charlson comorbidity score, median (IQR) 4 (2–6) 2 (1–4) <0.01
Coronary artery disease, n (%) 209 (59) 1 933 (48) <0.01
Congestive heart failure, n (%) 191 (54) 1 439 (36) <0.01
Cerebrovascular disease, n (%) 63 (18) 713 (18) 1
Diabetes, n (%) 218 (61) 1 712 (43) <0.01
Malignancy, n (%) 153 (43) 1 560 (39) 0.12
Liver disease, n (%) 27 (8) 644 (16) <0.01
Peripheral vascular disease, n (%) 21 (6) 115 (3) <0.01
Chronic kidney disease, n (%) 204 (57) 551 (14) <0.01
Hypertension, n (%) 309 (87) 2 738 (68) <0.01
Dementia, n (%) 25 (7) 334 (8) 0.40
Proteinuria, n (%) 9 (3) 13 (0.3) <0.01
Hematuria, n (%) 125 (35) 1 060 (26) <0.01
Conditions during index hospitalization
Sepsis, n (%) 49 (14) 807 (20) <0.01
Aortic aneurysm repair, n (%) 10 (3) 155 (4) 0.32
Cardiac surgery, n (%) 10 (3) 155 (4) 0.32
Mechanical ventilation, n (%) 163 (46) 2 209 (55) <0.01
Hospital type
Teaching Hospital, n (%) 173 (49) 1 980 (49) 0.84
aIn the 5 years preceding hospital admission.
bIn the 5 years preceding the hospital discharge date except chronic kidney disease which had a lookback period of 5 years preceding the hospital admission date.
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1,475, 33.7% of total cohort) were older (68 vs. 56 years,
p <0.01), more likely to have seen a nephrologist (30%
vs. 22%, p < 0.01), and had a higher prevalence of pre-
exisiting comorbidities (including cardiac disease (57%
vs. 43%, p < 0.01), congestive heart failure (49% vs. 28%,
p < 0.01), diabetes (48% vs. 40%, p < 0.01), cancer (49% vs.
33%, p < 0.01), chronic kidney disease (19% vs. 10%, p <
0.01), and hypertension (76% vs. 63%, p < 0.01) (Table 2).Outcomes
After a mean follow-up of 2.4 years, the cumulative in-
cidence of chronic dialysis was 13.5% by the Kaplan-
Meier method, and 10.3% using the competing risk
approach. (Figure 2) The cumulative incidence of all-
cause mortality was 54.2%, after a mean follow-up of 3.0years, and 1475 patients died prior to the initiation of
chronic dialysis therapy.
Predictors of chronic dialysis
Previous nephrology consultation (adjusted hazard ratio
(aHR) 2.12, 95% CI 1.67-2.70), Charlson comorbidity
score (aHR 1.17; 95% CI 1.11-1.24 per unit increase), a
history of chronic kidney disease (aHR 4.04, 95% CI
3.14-5.2), and pre-existing hypertension (aHR 1.70; 95%
CI 1.21-2.37) were significantly associated with an in-
creased risk of chronic dialysis. Prior liver disease (aHR
0.42; 95% CI 0.28-0.63) and the receipt of mechanical
ventilation on the index hospitalization (aHR 0.78; 95%
CI 0.62-0.97) were inversely associated with chronic dia-
lysis. (Table 3) The c-statistics for the chronic dialysis
model using the cause-specific Cox approach was 0.66
(95% CI 0.62-0.71).
Table 2 Baseline characteristics of the cohort stratified by death during the follow-up period
Variable Death Alive p-value
N = 1,475 N = 2.908
Demographics and health utilization
Age, mean (SD) 68 (±14) 56 (±17) <0.01
Female gender, n (%) 589 (40) 1 040 (41) 0.61
Rural locale, n (%) 206 (14) 395 (14) 0.73
Pre-admission nephrology consultation, n (%)a 441 (30) 563 (22) <0.01
Pre-admission cardiology consultation, n (%)a 750 (51) 1 085 (43) <0.01
Comorbid diseaseb
Charlson comorbidity score, median (IQR) 4 (2–5) 2 (0–3) <0.01
Coronary artery disease, n (%) 842 (57) 1 091 (43) <0001
Congestive heart failure, n (%) 718 (49) 721 (28) <0.01
Cerebrovascular disease, n (%) 349 (24) 364 (14) <0.01
Diabetes, n (%) 700 (48) 1012 (40) 0.08
Malignancy, n (%) 715 (49) 845 (33) <0.01
Liver disease, n (%) 214 (15) 430 (17) 0.05
Peripheral vascular disease, n (%) 82 (6) 33 (1) <0.01
Chronic kidney disease, n (%) 286 (19) 265 (10) <0.01
Hypertension, n (%) 1 122 (76) 1616 (63) <0.01
Dementia, n (%) 182 (12) 152 (6) <0. 01
Hematuria, n (%) 457 (31) 603 (24) 0.5
Proteinuria, n (%) 6 (0.4) 7 (03) <0.01
Conditions during index hospitalization
Sepsis, n (%) 280 (19) 527 (21) 0.2
Aortic aneurysm repair, n (%) 69 (5) 86 (3) 0.04
Cardiac surgery, n (%) 152 (10) 320 (13) 0.03
Mechanical ventilation, n (%) 705 (48) 1 504 (59) <0.01
Hospital type
Teaching hospital, n (%) 746 (48) 1 406 (51) 0.15
aIn the 5 years preceding hospital admission.
bIn the 5 years preceding the hospital discharge date except chronic kidney disease which had a lookback period of 5 years preceding the hospital admission date.
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Older age (aHR 1.03; 95% CI 1.02-1.04 per year), Charlson
comorbidity score (aHR 1.21; 95% CI 1.18-1.23 per unit
increase in the score), heart failure (aHR 1.18; 95% CI
1.05-1.33), peripheral vascular disease (aHR 1.32; 95% CI
1.05-1.66), and dementia (aHR 1.30; 95% CI 1.10-1.50)
were significantly associated with a higher risk of death.
Pre-existing diabetes (aHR 0.87; 95% CI 0.77-0.97), and
the receipt of mechanical ventilation during the index
hospitalization (aHR 0.79; 95% CI 0.71-0.87), were associ-
ated with a lower risk of death. (Table 3) The c-statistics
for the all-cause mortality models using the cause-specific
Cox approach was 0.71 (95% CI 0.67-0.76).
Competing risk approach
In multivariable analysis using a Fine and Gray regres-
sion model that treated death as a competing event, ahistory of chronic kidney disease (sHR 3.86; 95% CI 2.99-
4.98), a history of previous nephrology consultation (sub-
distribution hazard ratio (sHR) 2.03, 95% CI 1.61-2.58),
Charlson comorbidity index score (sHR 1.10; 95% CI 1.05-
1.15), and hypertension (sHR 1.82; 95% CI 1.28- 2.58)
were significantly associated with the need for chronic dia-
lysis initiation. The presence of liver disease (sHR 0.43;
95% CI 0.29-0.64) was significantly associated with a lower
risk for the initiation of chronic dialysis (Table 4).
Discussion
Escalating comorbidity, pre-existing kidney disease, as
reflected by a diagnosis of CKD or a visit to a nephrologist,
and pre-existing hypertension predicted progression to
chronic dialysis in a cohort of patients who survived an
episode of dialysis-requiring AKI. Similarly, increasing
age, a higher Charlson comorbidity score; the presence
Figure 2 Cumulative incidence of chronic dialysis initiation
by model.
Table 4 Multivariable model for initiation of chronic




Female gender 0.95 (0.77-1.18)
Previous nephrology consultation 2.03(1.61-2.58)*
Charlson comorbidity index 1.10 (1.05-1.15)*
Coronary artery disease 0.87 (0.67-1.13)
Congestive heart failure 1.21 (0.94-1.56)
Diabetes 1.18 (0.93-1.51)
Liver disease 0.43 (0.29-0.64)*
Peripheral vascular disease 0.90 (0.56-1.46)
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of post-AKI mortality.
Although the link between AKI and subsequent CKD
has been extensively described, patients with the most
severe form of AKI who require acute dialysis are theTable 3 Multivariable-adjusted cause-specific hazards
ratio for chronic dialysis and all-cause mortality





Age 0.99 (0.99-1.00) 1.03 (1.02-1.04)*
Female gender 0.95 (0.76-1.18) 0.91(0.82-1.01)
Previous nephrology consultation 2.12 (1.67-2.70)* 1.02 (0.91-1.16)
Charlson comorbidity index 1.17 (1.11-1.24)* 1.21 (1.18-1.23)*
Coronary artery disease 0.86 (0.67-1.10) 0.92 (0.82-1.03)
Congestive heart failure 1.22 (0.96-1.56) 1.18 (1.05-1.33)*
Diabetes 1.15 (0.0.91-1.46) 0.87 (0.77-0.97)*
Liver disease 0.42 (0.28-0.63)* 1.07 (0.92-1.25)
Peripheral vascular disease 1.03 (0.66-1.62) 1.32 (1.05-1.66)
Chronic kidney disease 4.04 (3.14-5.20)* 1.01 (0.87-1.17)
Hypertension 1.70 (1.21-2.37)* 0.93 (0.82-1.06)
Dementia ——— 1.30 (1.10-1.50)*
Hematuria 1.10 (0.88-1.37) 1.10 (0.99-1.23)
Proteinuria 1.85 (0.94-3.67) ———
Sepsis 0.84 (0.62-1.15) ———
Receipt of mechanical ventilation
during index admission
0.78 (0.62-0.97)* 0. 79 (0.71-0.87)*
*p < 0.05.sub-population of patients with the highest risk of pro-
gression [16]. However, we found that only 10% of these
patients progress to chronic dialysis thus highlighting the
need to identify risk factors for such progression in order
to target potential interventions to those who are most
likely to benefit. Moreover, due to our study design, pa-
tients with severe AKI who did not recover renal function
or those who initiated chronic dialysis within 90 days of
discharge were excluded from our cohort; and therefore,
the contribution of AKI to the progression to chronic dia-
lysis is likely higher than our data suggests.
Similar to our report, studies by Stads et al. [17], Ishani
et al. [18], and Lo et al. [3] have demonstrated the strong
association between pre-existing CKD and the need for
subsequent chronic dialysis. It is not surprising that pre-
existing CKD is one of the most important predictors
modifying the relationship between AKI and progressive
CKD as has been demonstrated in multiple studies [19-22].
The impact of even a modest acute insult to already com-
promised kidneys may be devastating. Although the bio-
logical mechanism linking CKD progression after AKI has
not fully been elucidated, it has been postulated that the
combination of acute endothelial injury leading to vascular
dropout, and nephron loss followed by glomerular hyper-
trophy and the development of fibrosis may all play a role
[23,24]. This may be more pronounced in patients with
underlying CKD who may already possess a limited renal
reserve, such that an episode of AKI may tip them into
the need for chronic dialysis more easily than those with-
out a background history of renal disease. Recognizing the
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hanced our capture of patients with underlying kidney dis-
ease by examining prior visits to a nephrologist, which we
postulated as a reasonable surrogate for kidney disease.
Both prior visits to a nephrologist and/or diagnosed CKD
together capture the notion that patients who develop se-
vere AKI with already-compromised kidney function are
at substantially higher of accelerated and irreversible kid-
ney dysfunction once the acute illness resolves.
As demonstrated by Chawla et al., we found that hyper-
tension was another important predictor of chronic dialy-
sis among AKI-D survivors [25]. Systemic hypertension is
a potent contributor to the development of arterioscler-
osis, tubulointerstitial fibrosis and glomerulosclerosis, all
of which may hasten the decline in kidney function
[26,27]. Patients with a history of hypertension may have
underlying unrecognized CKD, despite having a “normal”
serum creatinine level [28,29]. Subsequent renal injury
imparted by an episode of AKI may not only unmask this
underlying damage, but also lead to its acceleration.
The inverse association between liver disease and chronic
dialysis was surprising given that these patients are prone
to ongoing renal injury from changes in autoregulation due
to arteriolar vasodilation and neuroendocrine changes asso-
ciated with decompensated liver disease [30]. Perhaps, this
group of patients underwent acute dialysis during their
hospitalization as a bridge toward subsequent liver trans-
plantation. Indeed, serum creatinine is a component of the
Model for End-Stage Liver Disease (MELD) score which is
used for organ allocation in patients with liver disease [31].
Severe AKI associated with liver disease is associated with
extremely high mortality [32]. We speculate that the few in-
dividuals with liver disease who survived a hospitalization
associated with AKI-D had a relatively lower burden of co-
morbidity. By the same token, the apparent “protective” as-
sociation between mechanical ventilation on the index
hospitalization and both chronic dialysis and all-cause mor-
tality suggests that the sickest patients who received mech-
anical ventilation likely died during the hospitalization or
shortly thereafter. Those fortunate to survive to 90 days fol-
lowing discharge were a selected group who by virtue of
surviving the acute phase of their illness, were destined to
have better outcomes.
Since the risk of death after an episode of AKI-D far out-
strips that of chronic dialysis, predicting this outcome is
also of vital clinical interest. As such, our study also delin-
eated a number of predictors of post-AKI mortality includ-
ing increasing age, a higher Charlson comorbidity score;
the presence of heart failure, diabetes and dementia; as
well as an inverse relationship with the receipt of mechan-
ical ventilation. In line with previous work by Stads et al.,
preexisting CKD was strongly associated with death,
which may relate to the link between CKD and cardiovas-
cular disease [17,33].Our study has several strengths. Most notably, it is the
first to determine the predictors of initiating chronic dialy-
sis in a cohort of survivors of severe AKI using a competing
risk approach. Although previous studies of AKI survivors
have reported similar predictors, there are notable differ-
ences in methodology, case-mix and outcome ascertain-
ment between these studies and ours [3,5,18,25,34]. Our
use of a competing risk approach, may have avoided over-
estimating the cumulative incidence of the progression to
chronic dialysis in survivors of severe AKI [35], and also
gave us more robust effect estimates for our predictors
[35]. Finally, our study was conducted in a jurisdiction with
universal access to medical services and our databases re-
flect the entire population, maximizing generalizability.
Though non-dialysis requiring CKD following AKI - is
common and potentially problematic, we focused our at-
tention on the extreme form of CKD, chronic dialysis,
which has the most profound implications for quality of life
and survival [2].
Our results have several potential implications. First,
the identification of novel predictors of chronic dialysis
in survivors of severe AKI may help improve the follow-
up of these patients by selectively referring to nephrolo-
gists those patients who possess characteristics which
place them at a high risk of progression. There is com-
pelling data regarding the positive role that nephrologists
may play in survivors of severe AKI; however, only a small
proportion of severe AKI survivors are referred to a neph-
rologist for follow-up [2,11]. This may be related to lim-
ited access to nephrologists or an under-appreciation of
the risk for progressive CKD following AKI. Alternatively,
a select number of patients with pre-existing chronic kid-
ney disease may already be followed by a nephrologist
prior to their episode of AKI, and this continuity in care
persists after the episode; thereby, obviating the require-
ment of a new referral. Second, knowledge of predictors of
chronic dialysis may allow for the creation of a predictive
model that can stratify AKI survivors at highest risk for
progression to CKD for inclusion in clinical trials.
Several limitations merit consideration. First, our reli-
ance on administrative codes for diagnoses and proce-
dures limited our ability to better characterize the cohort
and incorporate potentially vital data (eg, severity of acute
illness, laboratory data) in to our models. In particular, the
absence of pre-hospitalization laboratory data, most not-
able serum creatinine to estimate the glomerular filtration
rate and information on proteinuria, is an important limi-
tation [22,25]. As an alternative, we could only describe
CKD using administrative coding, which is highly specific
but poorly sensitive (median sensitivity 41%; median speci-
ficity 98%) [36], and by the surrogate of prior visits with a
nephrologist which is an important shortcoming. Moreover,
the administrative databases that we used did not contain
data (laboratory and clinical data), which would have
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APACHE scores). As these scores are useful predictors of
outcome failure to account for them in our propensity
score may have also contributed to confounding. Our in-
ability to access preadmission laboratory data also pre-
cluded us from conducting more rigorous analyses with
more robust measures of chronic kidney disease. Similarly,
we had no way of evaluating the extent of kidney function
recovery at the conclusion of the acute illness. Compro-
mised residual kidney function following an episode of
acute kidney injury is likely an important predictor of pro-
gression to chronic dialysis. Our definition for the receipt
of chronic dialysis may have misclassified individuals who
truly developed end-stage renal disease, but who died in
the first 90 days after commencing chronic dialysis. How-
ever, our definition for the receipt of chronic dialysis is
widely accepted, and has been used in multiple studies
[5,11]. In addition, while it is interesting that greater global
comorbidity, as expressed via the Charlson score, was asso-
ciated with chronic dialysis and death, we could not identify
which aspect(s) of the multicomponent Charlson score was
most important. Ultimately, our predictive models showed
limited discriminatory capacity suggesting that several fac-
tors that our datasets could not capture could have been
relevant in anticipating important clinical outcomes fol-
lowing an episode of AKI. Moreover, we only examined a
cohort of individuals who experienced the most severe
form of AKI. In this regard, our findings may not be
generalizable to individuals experiencing less severe yet
much more common forms of AKI.
Conclusions
Using a competing risk model, we have demonstrated
important predictors of progression to chronic dialysis
in survivors of a hospitalization complicated by AKI re-
quiring dialysis. Greater appreciation of the link between
AKI and CKD is appropriately accompanied by calls for
greater nephrology follow-up for AKI survivors. Our re-
sults identify patients with characteristics that associate
with a high risk of kidney disease progression and death
who should be targeted for closer post-discharge follow-
up. Further studies to develop and validate a more ro-
bust predictive model, will help optimize outcomes of
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